Muscadine Grape Skin Extract.

Muscadine skin carries ellagitannins that gut bacteria convert stepwise to ellagic acid and then to urolithins, and only some people carry the converting organisms. Supplying urolithin A gives the end metabolite regardless of that conversion capacity.

Resveratrol is the stilbene phytoalexin grape skin produces, so it sits in the same fraction as the muscadine anthocyanins and adds a defined dose of it. Extract stilbene content varies with vintage and processing, and a standardised addition sets a floor.

Pterostilbene is the dimethylated form of resveratrol and resists first-pass glucuronidation far better, so it survives where the parent stilbene is largely conjugated. Pairing covers both the rapidly conjugated and the persistent stilbene.

The seed carries oligomeric proanthocyanidins and the skin carries anthocyanins and stilbenes, two different flavonoid fractions of one fruit. Combining them reconstructs the whole-berry polyphenol profile.

Quercetin stacks with anthocyanins through copigmentation, which stabilises the anthocyanin chromophore in solution. Both also feed the same one-electron redox pool, where an oxidised phenoxyl radical can be reduced back by a neighbouring phenol.

Ascorbate donates an electron to the phenoxyl radical left after a polyphenol has quenched an oxidant, returning it to the reduced form. That recycling step is the classic antioxidant network relationship.

Tocopherol handles the lipid membrane phase while grape polyphenols sit in the aqueous phase, and the tocopheroxyl radical is reduced at the interface by the water-side phenols. The two phases cover each other.

Piperine inhibits intestinal UDP-glucuronosyltransferase, the enzyme that conjugates dietary polyphenols on first pass. Less conjugation means more of the parent polyphenol reaches circulation.

Galloyl and catechol groups on grape polyphenols chelate ferric iron in the gut lumen and form complexes that are poorly taken up. Separating the two by a couple of hours keeps both intact.

Grape stilbenes and flavonoids damp platelet aggregation responses, and EPA shifts eicosanoid production toward the less aggregatory series. The two effects add on the same normal clotting process.

Muscadine skins carry ellagitannins and ellagic acid, which the body does not absorb well intact. Resident colonic bacteria hydrolyse and convert them stepwise to urolithins, and the capacity to reach urolithin A differs between people. A live culture is proposed on that conversion step, not on a combination trial.

Lactobacillus strains carry glycosidase and esterase activity that cleaves sugar and gallate groups off plant polyphenols. That releases smaller phenolics the gut wall can take up. The pairing is mechanistic and strain dependent rather than measured for this extract.

Most of an anthocyanin dose passes the small intestine and arrives in the colon, where the bacterial community decides what happens next. A fermentable fibre feeds that community. The rationale is substrate for the converters, not a direct effect on the polyphenols themselves.

Grape polyphenols quench radicals and are themselves oxidised in the process. Lipoic acid participates in the cellular recycling network that regenerates other reduced antioxidants. The pairing is a network argument, and it operates on redox markers rather than on a clinical endpoint.

N-acetylcysteine supplies cysteine, the rate-limiting substrate for glutathione. Polyphenol conjugation and the cell's own antioxidant defence both draw on that pool. Read the pairing as mechanistic support of normal antioxidant capacity.

Glutathione is the central thiol buffer inside cells and the cosubstrate for glutathione transferases. Flavonoid metabolites move through the same conjugating machinery. The relationship is biochemical rather than demonstrated in a combination study.

Catechins and grape flavonols are both glucuronidated and sulfated by UGT and SULT enzymes in the gut wall and liver. Taken together at high load they compete for the same conjugation capacity, which can raise or blunt circulating levels of either one. The antioxidant argument is additive, the metabolism argument is competitive, and both are worth stating.

Catechol and galloyl groups on grape polyphenols bind divalent metal ions in the gut lumen. That lowers the fraction of zinc available for uptake from the same meal. Separating the two by a couple of hours is ordinary formulation practice.

Calcium salts and polyphenol-rich extracts interact in the lumen, with complexes that neither party absorbs well. The effect is largest when both arrive in the same meal at high dose. Spacing is the practical answer.

Proline-rich and globular proteins bind polyphenols non-covalently, which is why a berry extract in a protein shake loses its astringency. Binding changes the delivery profile and can slow release rather than abolishing it. The pairing is a formulation decision with a real chemical basis.

Phospholipid complexes are a standard way to carry poorly permeable flavonoids across the intestinal membrane. Lecithin supplies the phosphatidylcholine that forms those complexes. This is formulation chemistry, and the extent of any gain depends on how the complex is made.

Phosphatidylcholine forms the amphiphilic shell used in phytosome preparations of plant polyphenols. The polyphenol sits at the polar head group and travels with the lipid. The mechanism is well described in formulation literature and is not specific to this extract.

Silymarin flavonolignans and grape flavonols both act on hepatic conjugation and antioxidant handling. Combining them stacks two polyphenol loads on the same enzymes. The support is mechanistic, and outcomes here are markers rather than clinical measures.